Simultaneous targeting of AMPK and mTOR is a novel therapeutic strategy against prostate cancer. Zhao G, Forn-Cuni G, Scheers M, Lindenbergh PP, et al. Cancer Lett 2024 Feb 7:216657. doi: 10.1016/j.canlet.2024.216657.

Read + Share

Amedeo Smart

Independent Medical Education

Zhao G, Forn-Cuni G, Scheers M, Lindenbergh PP, et al. Simultaneous targeting of AMPK and mTOR is a novel therapeutic strategy against prostate cancer. Cancer Lett 2024 Feb 7:216657. doi: 10.1016/j.canlet.2024.216657.
PMID: 38336289